Oral administration of l-arginine in patients with angina or following myocardial infarction may be protective by increasing plasma superoxide dismutase and total thiols with reduction in serum cholesterol and xanthine oxidase

Oxidative Medicine and Cellular Longevity

Volumn 2, Issue 4, 2009, Pages 231-237

  Tripathi, Pratima ^a   Chandra, M ^b   Misra, M K ^a  

^a UNIVERSITY OF LUCKNOW   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

L arginine, oxidative stress, myocardial injury, nitric oxide, myocardial infarction, acute angina

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGININE; ASCORBIC ACID; CARBONYL DERIVATIVE; CHOLESTEROL; ENDOTHELIN 1; SUPEROXIDE DISMUTASE; THIOL; XANTHINE OXIDASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PROTEIN EXPRESSION; VITAMIN BLOOD LEVEL;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADULT; AGED; ANGINA PECTORIS; ARGININE; CHOLESTEROL; ENDOTHELIN-1; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SULFHYDRYL COMPOUNDS; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ANGINA;

EID: 77953396132     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.4161/oxim.2.4.9233     Document Type: Article

References (47)

1. Cerconi C, Cargnoni A, Pasini E, Condorelli E, Curello S, Ferrari R. Evaluation of phospolipid peroxidation as malondialdehyde during myocardial ischemia and reperfusion injury. Am J Physiol 1991; 260:1057-61.
2. Dhalla NS, Panagia V, Singal PK, Makino N, Dixon IM, Eyolfson DA. Alterations in heart membrane calcium transport during the development of ischemia-reperfusion injury. J Mol Cell Cardiol 1988; 20:3-13.
3. Suzuki S, Kaneko M, Chapman DC, Dhalla NS. Alterations in cardiac contractile proteins due to oxygen free radicals. Biochim Biophys Acta 1997; 1074:95-100.
4. 2+/calmodulin protein kinase phosphorylation of cardiac SR proteins in ischemia-reperfusion. Am J Physiol 1999; 277:384-91.
5. 2+/ ATPase of the Sarcoplasmic reticulum in anesthesized dogs contributes to myocardial reperfusion injury. Cardiovasc Res 1997; 36:174-84.
6. Elmoselhi AB, Butcher A, Samson SE, Grover AK. Free radicals uncouple the sodium pump in pig coronary artery. Am J Physiol 1994; 266:720-8.
7. Goldhaber JI, Weiss JN. Oxygen free radicals and cardiac reperfusion abnormalities. Hyperten 1992; 20:118-27.
8. Gilham B, Papachristodoulou DK, Thomas JH. Will's biochemical basis of medicine. Butterworth-Heinemann (ed.,) 1997; 3:343-54.
9. 2 within human erythrocytes. Blood 1995; 84:325-30.
10. Bhakuni P, Chandra M, Misra MK. Oxidative stress parameters in erythrocytes of post reperfused patients with myocardial infarction. J Enz Inhibt Med Chem 2005; 20:377-81.
11. Bhakuni P, Chandra M, Misra MK. Effect of ascorbic acid supplementation on certain oxidative stress parameters in the post-reperfusion patients of myocardial infarction. Mol Cell Biochem 2006; 290:153-8.
12. Dwivedi VK, Chandra M, Misra PC, Misra MK. Effect of vitamin E on platelet enzymatic anti-oxidants in the patients of myocardial infarction. Ind J Clin Biochem 2005; 20:21-5. (Pubitemid 40363598)
13. Raghuvanshi R, Chandra M, Misra PC, Misra MK. Effect of vitamin E on the platelet xanthine oxidase and lipid per-oxidation in the patients of myocardial infarction. Ind J Clin Biochem 2005; 20:26-9. (Pubitemid 40363599)
14. Diaz MN, Frei B, Vita JA, Keaney JF. Anti-oxidants and atherosclerotic heart disease. N Engl J Med 1997; 337:408-16.
15. Wu G, Meininger CJ. Arginine nutrition and cardiovascular function. J Nutr 2006; 130:2626-9.
16. Bogle RG, Coade SB, Moncada S, Pearson JD, Mann GE. Bradykinin and ATP stimulate L-arginine uptake and nitric oxide release in vascular endothelial cells. Biochem Biophys Res Commun 1991; 180:926-32.
17. Brown AA, Hu FB. Dietary modulation of endothelial function: Implication for cardio vascular disease. Am J Ciln Nutr 2001; 73:673-86.
18. Kehrer JP, Piper HM, Sies H. Xanthine oxidase is not responsible for reoxygenation injury in isolated-perfused rat heart. Free Rad Res Commun 1987; 3:69-78.
19. Bolli R. Oxygen derived free radicals and myocardial reperfusion injury. An over view. Cardiovasc Drug Ther 1991; 5:249-68.
20. Otani H, Engelman RM, Rousou JA, Breyer RH, Lemeshow S, Das DK. Cardiac performance during reperfusion improved by pretreatment with oxygen free radical scavengers. J Thorac Cardiovasc Surg 1986; 91:290-5.
21. Fox KAA. Myocardial protection: the pathophysiology of reperfusion and reperfusion injury. In Reperfusion injury. A clinical perspective. Yellon DM, Jennings RB, (eds.,) Raven Press, New York 1992; 151-65.
22. De Lorgeril M, Richard MJ, Arnaud J, Boissonnat P, Guidollet J, Durcau G, et al. Lipid peroxides and anti-oxidant defenses in the accelerated transplantation associated coronary arteriosclerosis. Am Heart J 1993; 125:974-80.
23. Gutteridge JMC. Iron promotes Fenton reaction and lipid per oxidation can be released from hemoglobin by peroxides. FEBS Lett 1986; 201:291-5.
24. Winkler BS. In vitro oxidation of ascorbic acid and its prevention by GSH. Biochim Biophys Acta 1987; 925:258-64.
25. Basu S, Som S, Deb S, Mukherjee D, Chatterjee IB. Dehydroascorbic acid reduction in human erythrocytes. Biochim Biophys Res Commun 1979; 90:1335-40.
26. Wells WW, Xu DP, Yang YF, Rocque PA. Mammalian thioltransferase (glutaredoxin) and protein disulphide isomerase have dehydroascorbic reductase activity. J Biol Chem 1990; 265:15361-4.
27. Barton D. Prevention of atherosclerosis with dietary antioxidants: Fact or Fiction? Symposium: Formation, metabolism and physiological effects of oxidatively modified low density lipo-protein. J Nutr 1996; 126:1067-71.
28. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in Ischemic-reperfusion injury. Cardiovasc Res 2000; 47:446-56.
29. Anke-G Lenz, Ulrich C, Shmuel S, Levine RL. Determination of carbonyl groups in oxidatively modified proteins by reduction with titrated Sodium Borohydride. Anal Biochem 1989; 177:419-25.
30. Buckberg GD. Studies of hypoxemic/reoxygenation injury. Linkage between cardiac function and oxidant damage. J Thorac Cardiovasc Surg 1995; 110:1164-70.
31. Ihnken K, Morita K, Buckberg GD, Sherman MP, Allen BS. Studies of hypoxemic/ reoxygenation injury without aortic clamping II. Evidence for reoxygenation damage. J Thorac Cardiovasc Surg 1995; 110:1171-81.
32. Mizuno A, Baretti R, Buckberg GD, Young H, Vinten-Johansen J, Ma X. Endothelial stunning and myocyte recovery after reperfusion of jeopardized muscle: a role of L-arginine blood cardioplegia. J Thorac Cardiovasc Surg 1997; 113:379-89.
33. Wan-Teng Lin, Suh-Ching Yang, Shiow-Chwen Tsai, Chi-Chang Huang, Ning-Yuean Lee. L-arginine attenuates xanthine oxidase and myeloperoxidase activities in hearts of rats during exhaustive exercise. Brit Jour Nutr 2006; 95:67-75.
34. Engelman DT, Watanabe M, Maulik N, Cordis GA, Engelman RM, Rousou JA, et al. L-arginine reduces endothelial inflammation and myocardial stunning during ischemia/ reperfusion. Ann Thorac Surg 1995; 60:1275-81.
35. Theilmeier G, Chan JR, Zalpour S, Anderson B, Wang B. Adhesiveness of Mononuclear Cells in Hypercholesterolemic Humans is normalized by Dietary L-Arginine. Arteriosclero Thromb Vasc Biol 1997; 17:3557-64. (Pubitemid 28028568)
36. Tousoulis D, Boger RH, Antoniades C, Siasos G, Stefanadi E, Stefanadis C. Mechanisms of disease: L-arginine in coronary atherosclerosis-a clinical perspective. Nat Clin Pract Cardiovas Med 2007; 4:274-83. (Pubitemid 46672116)
37. Rossitch E Jr, Alexander E, Black P, Cooke JP. L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. J Clin Invest 1991; 87:1295-9.
38. Hurson M, Regan MC, Kirk SJ, Wasserkrug HL. Barbul A.1 Metabolic Effects of Arginine in a Healthy Elderly Population. J Parent Enter Nutr 1995; 19:227-30.
39. Korbut R, Bieron K, Gryglewski RJ. Effect of L-arginine on plasminogen-activator inhibitor in hypertensive patients with hypercholesterolemia. The New Engl J Med 1993; 328:287-8.
40. Misra HP, Fridovich I. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay of superoxide dismutase. J Biol Chem 1972; 247:3170-5.
41. Fried R, Fried LW. Xanthine Oxidase (Xanthine Dehydrogenase) Methods. Enzymat Analys 1945; 2:644-9.
42. Omaye ST, Turnbull JD, Sauberlich HE. Selected methods for determination of ascorbic acid in animal cells, tissues and fluids. Methods Enzymol 1979; 62:3-11.
43. Hu M. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994; 233:380-2.
44. Ohkawa H, Oshishi N, Yagi K. Assay of lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95:351-8.
45. Levini RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186:464-78.
46. Sperry WM, Webb M. A revision of Schoenheimer-Sperry method for cholesterol determination. J Biol Chem 1950; 187:97-106.
47. Lowry OH, Rosebrough NJ, Farr AL, Randall RG. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193:265-75.